Mechanistically, MM-BMSCs transferred EVs containing low levels of the tumor suppressor miR-15a and high levels of IL6 and CCL2 into MM cells, inducing their proliferation and survival [65]. The gene discussed is CCL2; the disease is Miyoshi myopathy.